Skip to main content
SpringerLink
Log in

Condom-free conception cost effective if man HIV positive

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. one dose of tenofovir disoproxil fumarate or emtricitabine/tenofovir disoproxil fumarate (Truvada) on the morning of the peak level of luteinising hormone and a second dose the following morning

  2. 2013 Canadian dollars

Reference

  • Letchumanan MG, et al. An economic evaluation of conception strategies for heterosexual serodiscordant couples where the male partner is HIV-positive. Antiviral Therapy : 7 Apr 2015. Available from: URL: http://doi.org/10.3851/IMP2956

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Condom-free conception cost effective if man HIV positive. PharmacoEcon Outcomes News 726, 12 (2015). https://doi.org/10.1007/s40274-015-2060-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2060-7

Search

Navigation